Breast Cancer
Temporary Interruption of Endocrine Therapy to Attempt Pregnancy in Patients With Breast Cancer
You're currently viewing OncGenius as a guest. To save your results, create an account or log in.
Advertisement
Temporary Interruption of Endocrine Therapy to Attempt Pregnancy in Patients With Breast Cancer
ASCO 2023: International Cooperation and Pediatric Leukemia Outcomes
NCCN Guidelines: Acute Myeloid Leukemia, Version 3.2023, Focus on BPDCN
Psilocybin Therapy for Patients With Cancer and Major Depression Disorder
Understanding Prostate Cancer Incidence in Transgender Women
NCCN Guidelines: Esophageal and Esophagogastric Junction Cancers, Version 2.2023
AACR 2023: Does Pembrolizumab Improve Outcomes in Biliary Tract Cancer?
Blinatumomab Plus Interfant-06 Chemotherapy in Infants With KMT2A-Rearranged ALL
Poverty’s Impact on Outcomes in Pediatric Acute Lymphoblastic Leukemia
Dietary Intervention for Improvement of Side Effects Among DLBCL Survivors
Mediterranean Diet and Outcomes Among Patients With Advanced Melanoma Receiving Immunotherapy
Ide-cel vs Standard Regimens for Patients With Relapsed and Refractory Multiple Myeloma
Rate of COVID-19 Vaccination Among Patients With Cancer Who Tested Positive for SARS–CoV-2
Radiotherapy Techniques for Patients With Locally Advanced, Recurrent Nasopharyngeal Cancer
Determining Risk of Relapse After Bone Marrow Transplant Among Patients With AML
Rapid Changes in Colorectal Cancer Statistics: American Cancer Society Report
Ethnic Disparities in Pediatric Leukemia Survival and U.S./Mexico Border Residence
ASCO GU 2023: Rucaparib or Physician’s Choice in Metastatic Castration-Resistant Prostate Cancer
Is Childhood Leukemia Linked to Maternal Infection During Pregnancy?
ASCO GU 2023: Talazoparib Plus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Ponatinib vs Imatinib for Newly Diagnosed Patients With Ph-Positive ALL
New Ovarian Cancer Risk-Control Guidance Suggests Early Surgical Intervention
Food Insecurity and Receipt of SNAP Benefits Among Pediatric Patients With ALL
ASCO GI 2023: NAPOLI-3 Trial in Metastatic Pancreatic Ductal Adenocarcinoma
ASCO GI 2023: Zolbetuximab Plus mFOLFOX6 For Certain Patients With Advanced Gastric Cancers
ASH 2022: Zanubrutinib in Patients With Relapsed or Refractory CLL/SLL
ASH 2022: Efficacy of Triplet Combinations in Acute Myeloid Leukemia
Safety and Efficacy of Sotorasib in KRAS-Mutated Pancreatic Cancer
ASH 2022: Impact of Momelotinib on Patient-Reported Quality of Life for Patients With Myelofibrosis
ASH 2022: Talquetamab for Relapsed or Refractory Multiple Myeloma
Risk of ALCL Following Postmastectomy Implant Reconstruction
SABCS 2022: First-Line Ribociclib Plus Endocrine Therapy in Patients With Aggressive Breast Cancer
ASH 2022: Re-evaluating the Standard of Care in Mantle Cell Lymphoma
Patients With Multiple Myeloma Receiving Salvage Treatment After BCMA-Directed CAR T-Cell Therapy
Integrative Approaches to Managing Pain in Patients With Cancer: SIO/ASCO Guideline
Subset of Patients With a Very Low Risk of Dying From Melanoma
NCCN Guidelines for Pediatric Aggressive Mature B-Cell Lymphomas (Version 3.2022)
Real-World Cost of Pediatric ALL Care Among Commercially Insured Patients
ASTRO 2022: A Novel Approach for Radiotherapy in Orbital Indolent B-Cell Lymphoma
ESMO 2022: Pembrolizumab and Chemoradiation for Locally Advanced Head and Neck Cancer
Radiopharmaceuticals for Treatment of Metastatic Castration-Resistant Prostate Cancer
Physician Survey: Breast Cancer Screening Among Transgender Patients
Anaplastic Large-Cell Lymphoma of the Breast: Incidence in the United States
ESMO 2022: COSMIC-313 Trial of Triplet Therapy in Advanced Renal Cell Carcinoma
Trends in Improvements in Survival Among Patients With DLBCL
Consumption of Ultraprocessed Foods and Colorectal Cancer Risk
ESMO 2022: Air Pollution and Non–Small Cell Lung Cancer Risk
ESMO 2022: SWOG S1801 Trial of Timing of Pembrolizumab in Resected Advanced Melanoma
Trends in Cutaneous T-Cell Lymphoma Incidence in the United States
Diet Quality and Survival Among Patients With Head and Neck Cancer
UV-Protective Behaviors Among American Indians and Alaskan Natives
Germline Testing for Patients With Lung Cancer: ASCO Plenary Series
Older Patients With Advanced Bladder Cancer: Care Planning Priorities
Dosing of Tisagenlecleucel Among Pediatric Patients With Leukemia and Improved Outcomes
Acute Leukemia Survival Outcomes Over Time in South Australia
Real-World Outcomes With Axicabtagene Ciloleucel Therapy for Large B-Cell Lymphoma
Multiple Myeloma: Caregiver Quality of Life and Psychological Distress
Phase III Trial Evaluates Quizartinib for FLT3-ITD–Positive AML
Zanubrutinib for Untreated Patients With CLL/SLL: SEQUOIA Trial
Rapid Recommendation Update to ASCO Guideline for Systemic Treatment of Melanoma
Trends in the Use of Medical Aid in Dying in the United States
ASCO 2022: Asciminib vs Bosutinib in Pretreated Patients With CML in Chronic Phase
Characteristics of Advanced Extranodal Natural Killer/ T-Cell Lymphoma and its Treatment
Results From Large Real-World Cohorts on Treatment Outcomes in Patients With Mantle Cell Lymphoma
Consumption of Sugar-Sweetened Beverages and Risk of Liver Cancer
ASCO 2022: Real-World Data on Maintenance Olaparib in BRCA-Mutated Ovarian Cancer
ASCO 2022: Crenolanib Combined With Chemotherapy in Newly Diagnosed FLT3-Mutant AML
ASCO 2022: Dostarlimab-gxly in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer
ASCO 2022: Nimotuzumab Plus Gemcitabine for KRAS Wild-Type Pancreatic Cancer
ASCO 2022: New Data on IDH2-Mutant Alleles and Endasidenib in AML
The Financial Burden of Thyroid Cancer Care in the United States
ASCO 2022: Sacituzumab Govitecan-hziy for HR-Positive/HER2-Negative Advanced Breast Cancer
ASCO 2022: Measurable Residual Disease Testing as Prognostic Tool in Acute Myeloid Leukemia
ASCO 2022: Adding ASCT to Triplet/Maintenance Therapy for Newly Diagnosed Multiple Myeloma
ASCO 2022: Panitumumab Plus mFOLFOX6 for Certain Patients With Metastatic Colorectal Cancer
ASCO 2022: T-DXd in HER2-Low Unresectable and/or Metastatic Breast Cancer
ASCO 2022: Using ctDNA to Guide Adjuvant Chemotherapy in Colon Cancer
ASCO 2022: Ibrutinib Added to Bendamustine/Rituximab for Older Patients With Mantle Cell Lymphoma
ASCO 2022: State Public Welfare Spending and Disparities in Overall Survival
ASCO 2022: Disparities in Telemedicine Use for Patients With Cancer During the COVID-19 Pandemic
ASCO 2022: Black Patient Participation in Clinical Trials for Metastatic Breast Cancer
NCCN Guidelines for Non–Small Cell Lung Cancer (Version 3.2022)
CAR T-Cell Therapy: Rates of Rehospitalization and Emergency Department Visits Postinfusion
Addition of Ivosidenib to Azacitidine in Newly Diagnosed IDH1-Mutated AML
Total Burden of Psychiatric Disorders Across All Common Adult Cancers
Innate Cell Engager AFM13 Plus Natural Killer Cells for Lymphoma
MSI-H/dMMR Advanced Colorectal Cancer: Pembrolizumab vs Chemotherapy
Tislelizumab Plus Chemotherapy for Recurrent/Metastatic Nasopharyngeal Cancer: RATIONALE-309
CheckMate 816: Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC
NCCN Guidelines for the Management of Immunotherapy-Related Toxicities (Version 1.2022)
Rucaparib vs Standard-of-Care Chemotherapy for BRCA1/2-Mutated, Relapsed Ovarian Cancer
Immune Responses Among Patients With B-Cell Malignancies Post–COVID-19 Vaccination
Combined BCMA and CD19 CAR T-Cells in Relapsed or Refractory Multiple Myeloma
Pembrolizumab/Trametinib vs Gemcitabine in Addition to SBRT for Pancreatic Cancer
Immunotherapy Doublet in Patients With MSI-H/dMMR Metastatic Colorectal Cancer
Strategy for De-Escalating Radiation Therapy for Patients With Oropharyngeal Cancer
Darolutamide for Metastatic Hormone-Sensitive Prostate Cancer
Communication Skills Challenges for Advanced Practice Providers
Outcomes of Patients With an Ultra-Low–Risk 70-Gene Signature in the MINDACT Trial
Polatuzumab Vedotin-piiq Plus R-CHP vs R-CHOP in Previously Untreated DLBCL: POLARIX Trial
Combination Anti–PD-L1 and Anti–CTLA-4 Immunotherapy in Advanced Liver Cancer
Cancer During COVID-19: Resilience of Patients With Lung Cancer
Using PET Scans to Direct Therapy Decisions in Advanced Hodgkin Lymphoma
AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care
Mosunetuzumab for Relapsed or Refractory Aggressive and Indolent B-Cell Non-Hodgkin Lymphomas
TOPAZ-1 Trial: Durvalumab and Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer
Treatment Options for Patients With GIST Following Disease Progression
Managing Breakthrough Cancer Pain: Role of Shared Decision-Making
Tebentafusp-tebn for the Treatment of Unresectable or Metastatic Uveal Melanoma
T-DXd in Previously Treated Patients With Metastatic HER2-Mutant NSCLC
Case-Control Study of Risk of Cardiometabolic Risk Factors in Breast Cancer Survivors
BNT162b2 COVID-19 Vaccination and Immune Response in Patients Undergoing Anticancer Treatment
Dual Checkpoint Inhibition for Second-Line Treatment of Advanced Cervical Cancer
Emerging Therapies and Current Unmet Needs for Patients With Relapsed or Refractory DLBCL
Relatlimab and Nivolumab vs Nivolumab Alone in Untreated Advanced Melanoma
Treatment-Related Regret Among Men With Localized Prostate Cancer: Examining Potential Factors
COVID-19 Vaccination and SARS–CoV-2 Infection Among Patients With Cancer